Skip to main content

Inovio partners with non-profit organization to begin COVID-19 vaccine trial

Inovio Pharmaceuticals Inc on Thursday said it partnered with non-profit organization International Vaccine Institute to begin an early trial of the U.S. biotech's experimental COVID-19 vaccine on humans later this month.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.